Quantcast

Latest Becton, Dickinson and Company Stories

2014-07-31 08:34:20

- Announces revenues of $2.157 billion, an increase of 5.1 percent, or 4.6 percent on a foreign currency-neutral basis. FRANKLIN LAKES, N.J., July 31, 2014 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.157 billion for the third fiscal quarter ended June 30, 2014, representing an increase of 5.1 percent from the prior-year period, or 4.6 percent on a foreign currency-neutral...

2014-07-29 16:28:37

ReportsnReports.com offers "Microbial Identification Market Products (Consumables, Instruments, Services), Methods (Phenotypic, Genotypic) Application (Pharmaceutical, Diagnostic, Environmental, Food & Beverages), End User (Detection, Characterization) - Global Forecasts to 2019" global research report in its store. NEW YORK, July 29, 2014 /PRNewswire-iReach/ -- The global microbial identification market is categorized on the basis of products, methods, applications, end users, and...

2014-07-28 12:28:16

DALLAS, July 28, 2014 /PRNewswire/ -- The In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] - Forecast To 2017 research report says global industry is expected to reach $69.1 billion by 2017, at a CAGR of 7% from 2012 to 2017. The global in vitro diagnostics market...

2014-07-28 08:29:28

Assays bring an innovative solution to microbiology and molecular labs BALTIMORE, July 28, 2014 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company), (NYSE: BDX) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration for the BD ProbeTec(TM) Chlamydia trachomatis (CT) Q(x) Amplified DNA Assay and the BD ProbeTec(TM) Neisseria gonorrhoeae (GC) Q(x) Amplified DNA Assay on the BD Viper(TM) LT System. The BD Viper LT System...

2014-07-22 16:27:18

FRANKLIN LAKES, N.J., July 22, 2014 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 54.5 cents per common share payable on September 30, 2014 to holders of record on September 9, 2014. The indicated annual dividend rate is $2.18 per share. About BDBD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs....

2014-06-30 16:27:01

FRANKLIN LAKES, N.J., June 30, 2014 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its third fiscal quarter 2014 earnings conference call on Thursday, July 31, at 8:00 a.m. (ET). BD will issue a press release detailing the quarter's earnings earlier that morning. The webcast of the conference call, along with related slides, will be accessible through BD's website at www.bd.com/investors and will be available for...

2014-06-30 12:32:28

Company Commits to Support Every Newborn Action Plan as Part of 2014 Partners' Forum FRANKLIN LAKES, N.J., June 30, 2014 /PRNewswire/ -- As a global medical technology company dedicated to its purpose of "Helping all people live healthy lives," BD (Becton, Dickinson and Company) (NYSE: BDX), is proud to announce its support for and active participation in two key events aimed at reducing these needless deaths: the 5th Birthday and Beyond Coalition event held last week in Washington...

2014-06-17 08:29:36

First Healthcare Institution in the U.S. to Implement the System FRANKLIN LAKES, N.J., June 17, 2014 /PRNewswire/ -- BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced an agreement with The University of Texas MD Anderson Cancer Center for BD Cato(TM), a system that enhances safety and workflow efficiency in medication preparation via gravimetric and barcoding technology. MD Anderson Cancer Center will...

2014-06-11 08:31:01

The BD BACTEC(TM) FX40 Blood Culture Instrument now communicates with the BD EpiCenter(TM) Data Management System, enabling Laboratory Information System connectivity and Blood Volume Monitoring BALTIMORE, June 11, 2014 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its launch of the BD BACTEC(TM) FX40 Blood Culture System with connectivity to the BD EpiCenter(TM) Microbiology...

2014-06-05 12:29:55

FRANKLIN LAKES, N.J., June 5, 2014 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the publication of its 2013 Sustainability Report. This is BD's sixth annual Sustainability Report, highlighting progress in the past year. "The healthcare sector is in a period of great transition. We know this means that we will be faced with significant challenges and opportunities in the future," said Vincent A. Forlenza,...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related